Evidence map›Paper›PMID 31140149›Full record

ReviewMolecular biotechnology2019

CRISPR-Cas9 System for Genome Engineering of Photosynthetic Microalgae.

Vikas Kumar Patel, Niraja Soni, Venkatesh Prasad, Ajit Sapre, Santanu Dasgupta, Bhaskar Bhadra

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. CRISPR-Cas Technology TurnsMarine drugs · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Enhancing lipid production inFrontiers in microbiology · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Microalgae in Bioplastic Production: A Comprehensive Review.Arabian journal for science and engineering · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vikas Kumar PatelA2O - Biology, Reliance Technology Group, Reliance Industries Limited, RCP, Navi Mumbai, 400701, India.
Niraja SoniA2O - Biology, Reliance Technology Group, Reliance Industries Limited, RCP, Navi Mumbai, 400701, India.
Venkatesh PrasadA2O - Biology, Reliance Technology Group, Reliance Industries Limited, RCP, Navi Mumbai, 400701, India.
Ajit SapreA2O - Biology, Reliance Technology Group, Reliance Industries Limited, RCP, Navi Mumbai, 400701, India.
Santanu DasguptaA2O - Biology, Reliance Technology Group, Reliance Industries Limited, RCP, Navi Mumbai, 400701, India.
Bhaskar BhadraA2O - Biology, Reliance Technology Group, Reliance Industries Limited, RCP, Navi Mumbai, 400701, India. bhaskar.bhadra@ril.com.
Reliance Industries (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted genome editing using RNA-guided endonucleases is an emerging tool in algal biotechnology. Recently, CRISPR-Cas systems have been widely used to manipulate the genome of some freshwater and marine microalgae. Among two different classes, and six distinct types of CRISPR systems, Cas9-driven type II system has been widely used in most of the studies for targeted knock-in, knock-out and knock-down of desired genes in algae. CRISPR technology has been demonstrated in microalgae including diatoms to manifest the function of the particular gene (s) and developing industrial traits, such as improving lipid content and biomass productivity. Instead of these, there are a lot of gears to be defined about improving efficiency and specificity of targeted genome engineering of microalgae using CRISPR-Cas system. Optimization of tools and methods of CRISPR technology can undoubtedly transform the research toward the industrial-scale production of commodity chemicals, food and biofuels using photosynthetic cell factories. This review has been focused on the efforts made so far to targeted genome engineering of microalgae, identified scopes about the hurdles related to construction and delivery of CRISPR-Cas components, algae transformation toolbox, and outlined the future prospect toward developing the CRISPR platform for high-throughput genome-editing of microalgae.

Indexed as

BiotechnologyCRISPR-Cas SystemsGene EditingMicroalgaePhotobioreactorsAlgae biotechnologyAlgae CRISPRCRISPR–Cas9Genome editingPhotosynthetic cell factories

Identifiers

PMID31140149
OpenAlexW2947133722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.